Name
AS Bravo Pharmaceuticals
Registry code
14159974
VAT number
EE101938974
Type
AS - Joint Stock Company
Status
Registered
Foundation date
29.11.2016 (9)
Financial year
01.01-31.12
Capital
163 137.00 €
Activity
8699 -
28 873 €
-71 167 €
-246%
1 068 €
(estimate is approximate)
41 787 €
2
Submitted
No tax arrears
-170%
-25%
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Reena Singh
| 20% - 33 162.00 EUR | Board member | Direct ownership |
| Rakesh Pandey
| 80% - 129 975.00 EUR | Board member | Direct ownership |
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Competence Centre for Cancer Research AS 11015418 | 65% - 32 500.00 EUR | - | - |
| 2019 21.09.2021 | 2020 12.10.2021 | 2021 21.06.2022 | 2022 26.09.2023 | 2023 08.07.2024 | 2024 28.07.2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | 22 429 € | 52 458 € | 30 158 € | 4 775 € | 19 945 € | 28 873 € |
| Net profit (loss) for the period | -24 959 € | -48 043 € | -57 313 € | -100 122 € | -85 212 € | -71 167 € |
| Profit Margin | -111% | -92% | -190% | -2097% | -427% | -246% |
| Current Assets | 96 961 € | 47 456 € | 62 375 € | 56 781 € | 57 561 € | 46 661 € |
| Fixed Assets | 69 942 € | 251 515 € | 266 505 € | 250 602 € | 241 511 € | 237 898 € |
| Total Assets | 166 903 € | 298 971 € | 328 880 € | 307 383 € | 299 072 € | 284 559 € |
| Current Liabilities | 8 554 € | 56 507 € | 143 729 € | 109 217 € | 186 118 € | 242 772 € |
| Non Current Liabilities | 40 042 € | 0 € | 0 € | 0 € | 0 € | - |
| Total Liabilities | 48 596 € | - | - | - | - | - |
| Share Capital | 50 000 € | 50 200 € | 50 200 € | 163 337 € | 163 337 € | 335 337 € |
| Equity | 118 307 € | 242 464 € | 185 151 € | 198 166 € | 112 954 € | 41 787 € |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | 0 € | - | - | 2 |
| 2025 Q3 | 0 € | 1 743 € | 1 651 € | 2 |
| 2025 Q2 | 0 € | 6 288 € | 5 656 € | 1 |
| 2025 Q1 | 3 443 € | 4 324 € | 2 901 € | 1 |
| 2024 Q4 | 5 421 € | 4 683 € | 4 025 € | 1 |
| 2024 Q3 | 0 € | 5 223 € | 4 571 € | 1 |
| 2024 Q2 | 17 100 € | 7 415 € | 4 844 € | 1 |
| 2024 Q1 | 10 674 € | 7 013 € | 4 791 € | 1 |
| 2023 Q4 | 14 557 € | 7 123 € | 4 685 € | 1 |
| 2023 Q3 | 0 € | 6 808 € | 5 697 € | 1 |
| 2023 Q2 | 0 € | 4 141 € | 3 637 € | 1 |
| 2023 Q1 | 0 € | 5 485 € | 4 591 € | 1 |
| 2022 Q4 | 0 € | 5 519 € | 4 614 € | 1 |
| 2022 Q3 | 0 € | 5 376 € | 4 574 € | 1 |
| 2022 Q2 | 4 000 € | 5 377 € | 4 574 € | 1 |
| 2022 Q1 | 15 775 € | 5 453 € | 4 574 € | 1 |
